BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2324684)

  • 1. Lipid peroxides, glutathione peroxidase, high density lipoprotein subfractions and apolipoproteins in young adults.
    Luoma PV; Stengård J; Korpela H; Rautio A; Sotaniemi EA; Suvanto E; Marniemi J
    J Intern Med; 1990 Apr; 227(4):287-9. PubMed ID: 2324684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis.
    Dogru-Abbasoglu S; Kanbagli O; Bulur H; Babalik E; Oztürk S; Aykaç-Toker G; Uysal M
    Clin Biochem; 1999 Nov; 32(8):671-2. PubMed ID: 10638953
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.
    Luoma PV; Rautio A; Stengård J; Sotaniemi EA; Marniemi J
    Eur J Clin Pharmacol; 1990; 38(6):625-7. PubMed ID: 2373138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
    Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological variation data applied to the selection of serum lipid ratios used as risk markers of coronary heart disease.
    Ortolá J; Castiñeiras MJ; Fuentes-Arderiu X
    Clin Chem; 1992 Jan; 38(1):56-9. PubMed ID: 1733606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.
    Sewdarsen M; Desai RK; Vythilingum S; Shah N; Rajput MC
    Postgrad Med J; 1991 Feb; 67(784):159-64. PubMed ID: 2041847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.
    Barbir M; Wile D; Trayner I; Aber VR; Thompson GR
    Br Heart J; 1988 Nov; 60(5):397-403. PubMed ID: 3203033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects.
    Masarei JR; Puddey IB; Rouse IL; Lynch WJ; Vandongen R; Beilin LJ
    Atherosclerosis; 1986 Apr; 60(1):79-87. PubMed ID: 3707675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipid and apolipoprotein concentrations in healthy men on diets enriched in either canola oil or safflower oil.
    Wardlaw GM; Snook JT; Lin MC; Puangco MA; Kwon JS
    Am J Clin Nutr; 1991 Jul; 54(1):104-10. PubMed ID: 1905474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol--effect of selenium supplementation.
    Luoma PV; Sotaniemi EA; Korpela H; Kumpulainen J
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):469-72. PubMed ID: 6515133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study.
    Porkka KV; Viikari JS; Rönnemaa T; Marniemi J; Akerblom HK
    Acta Paediatr; 1994 Aug; 83(8):838-48. PubMed ID: 7981561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions.
    Anagnostis P; Stevenson JC; Crook D; Johnston DG; Godsland IF
    Maturitas; 2015 May; 81(1):62-8. PubMed ID: 25804951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
    Hamsten A; Walldius G; Dahlén G; Johansson B; De Faire U
    Atherosclerosis; 1986 Feb; 59(2):223-35. PubMed ID: 3083833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of clomipramine treatment on plasma lipoproteins and high density lipoprotein subfractions in healthy subjects.
    Skinner ER; Watt C; Reid IC; Besson JA; Ashcroft GW
    Clin Chim Acta; 1989 Sep; 184(2):147-54. PubMed ID: 2605782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.